MD Anderson researchers report early success of novel menin-targeted therapies in leukemia

Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations.

SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers – Biotech Investments

Issuer: SphingoTec GmbH / Key word(s): Financing/Investment 08.08.2024 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. SphingoTec GmbH has

August 9, 2024

Cord blood banking industry faces scrutiny over unproven claims and high costs

Some private UK biobanks may be misleading expectant parents about the value of storing umbilical cord blood to treat life-threatening diseases that may arise in

July 25, 2024

Calorie restriction and therapy combo reshapes gut microbiome, boosts mental health in women

Study finds that combining caloric restriction with psychological interventions significantly alters the gut microbiome and improves stress-related mental health in women.

August 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.